KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) Interest Expenses (2018 - 2025)

Historic Interest Expenses for Dynavax Technologies (DVAX) over the last 14 years, with Q3 2025 value amounting to $1.6 million.

  • Dynavax Technologies' Interest Expenses fell 329.61% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year decrease of 153.3%. This contributed to the annual value of $6.8 million for FY2024, which is 54.76% up from last year.
  • Dynavax Technologies' Interest Expenses amounted to $1.6 million in Q3 2025, which was down 329.61% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Interest Expenses registered a high of $4.7 million during Q1 2021, and its lowest value of $1.6 million during Q2 2025.
  • Its 5-year average for Interest Expenses is $1.9 million, with a median of $1.7 million in 2023.
  • Its Interest Expenses has fluctuated over the past 5 years, first plummeted by 6505.72% in 2021, then skyrocketed by 70.92% in 2024.
  • Over the past 5 years, Dynavax Technologies' Interest Expenses (Quarter) stood at $1.7 million in 2021, then rose by 0.3% to $1.7 million in 2022, then rose by 0.48% to $1.7 million in 2023, then increased by 0.71% to $1.7 million in 2024, then fell by 3.58% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q3 2025, $1.6 million for Q2 2025, and $1.7 million during Q1 2025.